These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29894077)

  • 1. Detection of high-risk human papillomavirus DNA and immunohistochemical expressions of p16, vimentin, ER, and PR in primary endocervical and endometrial adenocarcinomas.
    Xiong Y; Xiong YY; Xu ZG
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):517-521. PubMed ID: 29894077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
    Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS; Beck AH; Longacre TA
    Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProExC is a novel marker for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Esheba GE
    J Egypt Natl Canc Inst; 2013 Jun; 25(2):87-93. PubMed ID: 23719407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Diagnosis between Primary Endocervical and Endometrial Adenocarcinoma using Immunohistochemical Staining of Estrogen Receptor, Vimentin, Carcinoembryonic Antigen and p16.
    Yanaranop M; Ayuwat S; Nakrangsee S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S106-15. PubMed ID: 27266224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
    Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.
    Han CP; Lee MY; Tyan YS; Kok LF; Yao CC; Wang PH; Hsu JD; Tseng SW
    Virchows Arch; 2009 Oct; 455(4):353-61. PubMed ID: 19763614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of ER, VIM, CEA and p16 detection in the diagnosis and differential diagnosis of primary endocervical and endometrial adenocarcinomas].
    Hu WW; Tao JH; Li GM; Xu X; Yang XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):526-8, 531. PubMed ID: 20335127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
    McCluggage WG; Jenkins D
    Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
    Liao CL; Lee MY; Tyan YS; Kok LF; Wu TS; Koo CL; Wang PH; Chao KC; Han CP
    J Transl Med; 2009 May; 7():37. PubMed ID: 19476621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papilloma virus (HPV) DNA detection.
    McCluggage WG
    Am J Surg Pathol; 2004 Jul; 28(7):974. PubMed ID: 15223971
    [No Abstract]   [Full Text] [Related]  

  • 17. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Han CP; Lee MY; Kok LF; Wu TS; Cheng YW; Wang PH; Yue CH; Tyan YS
    Arch Gynecol Obstet; 2010 May; 281(5):845-50. PubMed ID: 19847454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
    Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP
    Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of HPV DNA detection and p16(INK4A) protein expression in diagnosis of endocervical adenocarcinoma].
    Meng ZL; Guo LN; Luo YF; Cao JL; Wan JW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):810-3. PubMed ID: 18346352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.